The in vitro treatment of monocytes with SLE and RA serum before RTX treatment promoted increased expression of pro‐thrombotic and pro‐inflammatory molecules (TF, VEGF, MCP‐1, IL‐8, IL‐1ß). This evidence concerns the gene TF and systemic lupus erythematosus.